187 related articles for article (PubMed ID: 27802340)
1. Cost-Effectiveness Analysis of Hepatitis B Vaccination Strategies to Prevent Perinatal Transmission in North Korea: Selective Vaccination vs. Universal Vaccination.
Lee D; Park SM
PLoS One; 2016; 11(11):e0165879. PubMed ID: 27802340
[TBL] [Abstract][Full Text] [Related]
2. Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence.
Hung HF; Chen TH
Vaccine; 2009 Nov; 27(48):6770-6. PubMed ID: 19735755
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness analysis of an additional birth dose of Hepatitis B vaccine to prevent perinatal transmission in a medical setting in Mozambique.
Klingler C; Thoumi AI; Mrithinjayam VS
Vaccine; 2012 Dec; 31(1):252-9. PubMed ID: 22902676
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of active-passive prophylaxis and antiviral prophylaxis during pregnancy to prevent perinatal hepatitis B virus infection.
Fan L; Owusu-Edusei K; Schillie SF; Murphy TV
Hepatology; 2016 May; 63(5):1471-80. PubMed ID: 26509655
[TBL] [Abstract][Full Text] [Related]
5. [Economic evaluation on strategy for preventing mother-to-child transmission of hepatitis B in Zhejiang Province].
Zeng YB; Luo ML; He HQ; Deng X; Xie SY; Fang Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Jul; 53(7):706-712. PubMed ID: 31288342
[No Abstract] [Full Text] [Related]
6. Cost-effectiveness of the controlled temperature chain for the hepatitis B virus birth dose vaccine in various global settings: a modelling study.
Scott N; Palmer A; Morgan C; Lesi O; Spearman CW; Sonderup M; Hellard M
Lancet Glob Health; 2018 Jun; 6(6):e659-e667. PubMed ID: 29773122
[TBL] [Abstract][Full Text] [Related]
7. Strategies for the prevention of perinatal hepatitis B transmission in a marginalized population on the Thailand-Myanmar border: a cost-effectiveness analysis.
Devine A; Harvey R; Min AM; Gilder MET; Paw MK; Kang J; Watts I; Hanboonkunupakarn B; Nosten F; McGready R
BMC Infect Dis; 2017 Aug; 17(1):552. PubMed ID: 28793866
[TBL] [Abstract][Full Text] [Related]
8. Selective Hepatitis B Birth-Dose Vaccination in São Tomé and Príncipe: A Program Assessment and Cost-Effectiveness Study.
Hagan JE; Carvalho E; Souza V; Queresma Dos Anjos M; Abimbola TO; Pallas SW; Tevi Benissan MC; Shendale S; Hennessey K; Patel MK
Am J Trop Med Hyg; 2019 Oct; 101(4):891-898. PubMed ID: 31392947
[TBL] [Abstract][Full Text] [Related]
9. Should Canada and the United States universally vaccinate infants against hepatitis B? A cost-effectiveness analysis.
Krahn M; Detsky AS
Med Decis Making; 1993; 13(1):4-20. PubMed ID: 8433635
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the cost-effectiveness of universal hepatitis B virus vaccination in Iran: a Markov model analysis.
Mokhtari AM; Barouni M; Moghadami M; Hassanzadeh J; Dewey RS; Mirahmadizadeh A
Hum Vaccin Immunother; 2021 Jun; 17(6):1825-1833. PubMed ID: 33734949
[TBL] [Abstract][Full Text] [Related]
11. Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations.
Margolis HS; Coleman PJ; Brown RE; Mast EE; Sheingold SH; Arevalo JA
JAMA; 1995 Oct; 274(15):1201-8. PubMed ID: 7563509
[TBL] [Abstract][Full Text] [Related]
12. The cost-effectiveness of two strategies for vaccinating US veterans with hepatitis C virus infection against hepatitis A and hepatitis B viruses.
Jakiche R; Borrego ME; Raisch DW; Gupchup GV; Pai MA; Jakiche A
Am J Med Sci; 2007 Jan; 333(1):26-34. PubMed ID: 17220691
[TBL] [Abstract][Full Text] [Related]
13. Cost-Effectiveness Analysis of Hepatitis B Immunization in Vietnam: Application of Cost-Effectiveness Affordability Curves in Health Care Decision Making.
Tu HAT; de Vries R; Woerdenbag HJ; Li SC; Le HH; van Hulst M; Postma MJ
Value Health Reg Issues; 2012 May; 1(1):7-14. PubMed ID: 29702830
[TBL] [Abstract][Full Text] [Related]
14. Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation.
Tilson L; Thornton L; O'Flanagan D; Johnson H; Barry M
Eur J Public Health; 2008 Jun; 18(3):275-82. PubMed ID: 18160389
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness analysis of a hepatitis B vaccination catch-up program among children in Shandong Province, China.
Jia Y; Li L; Cui F; Zhang D; Zhang G; Wang F; Gong X; Zheng H; Wu Z; Miao N; Sun X; Zhang L; Lv J; Yang F
Hum Vaccin Immunother; 2014; 10(10):2983-91. PubMed ID: 25483678
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of adding a birth dose of hepatitis B vaccine in the Dafra district of the Hauts-Bassins Region in Burkina Faso (NéoVac Study).
Gosset A; Diallo MY; Betsem E; Schaeffer L; Meda N; Vray M; Sombie R; Shimakawa Y; Boyer S
Vaccine; 2021 Jul; 39(33):4659-4670. PubMed ID: 34238606
[TBL] [Abstract][Full Text] [Related]
17. Economic evaluation of universal newborn hepatitis B vaccination in China.
Lu SQ; McGhee SM; Xie X; Cheng J; Fielding R
Vaccine; 2013 Apr; 31(14):1864-9. PubMed ID: 23384752
[TBL] [Abstract][Full Text] [Related]
18. A reappraisal of hepatitis B virus vaccination strategies using cost-effectiveness analysis.
Bloom BS; Hillman AL; Fendrick AM; Schwartz JS
Ann Intern Med; 1993 Feb; 118(4):298-306. PubMed ID: 8420448
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of antiviral prophylaxis during pregnancy for the prevention of perinatal hepatitis B infection in South Korea.
Lee D; Shin HY; Park SM
Cost Eff Resour Alloc; 2018; 16():6. PubMed ID: 29467596
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness analysis of antiviral treatment for pregnant women with high viral load to prevent hepatitis B virus vertical transmission.
Ma T; Lee LY; Aw MM; Lee GH
Singapore Med J; 2020 Jan; 61(1):24-27. PubMed ID: 31388686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
